trending Market Intelligence /marketintelligence/en/news-insights/trending/_ijgNv-ixH2JQT-fmRJVvA2 content esgSubNav
In This List

CanniMed receives Health Canada's approval to produce medical cannabis capsules

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

Blog

Essential IR Insights Newsletter - February 2023


CanniMed receives Health Canada's approval to produce medical cannabis capsules

Health Canada granted CanniMed Therapeutics Inc. license to produce medical cannabis capsules.

The company has initiated production of its CanniMed capsules following receipt of the production license.